Jalilvand Anahita, Kennedy Patrick J, Loftus John, Collins Courtney, Kellett Whitney, Wahl Wendy, Wisler Jon
Department of Surgery, Division of Trauma, Critical Care and Burn, at The Ohio State University Wexner Medical Center.
The Ohio State University College of Medicine, Columbus, Ohio.
Shock. 2025 Jun 1;63(6):844-850. doi: 10.1097/SHK.0000000000002568. Epub 2025 Mar 31.
Background: Obesity is associated with higher 90-day mortality compared to nonobese surgical patients. Bariatric surgery (BS) can reduce obesity-related comorbidities, even in those with persistent obesity. Objective: Evaluate the impact of prior BS on sepsis outcomes in surgical patients with obesity. Setting: University Hospital, United States. Methods: A single-institution retrospective review of all surgical patients with sepsis (SOFA≥2) was conducted. Patients were grouped into people with obesity and prior BS (OB/BS; n = 48), people with obesity without BS (OB; n = 717), nonobese (NOB; n = 574), and nonobese with prior BS (NOB/BS; n = 27). Demographic data, comorbidities, and sepsis presentation were compared. The primary outcome was cumulative 90-day mortality and survival. Results: Most OB/BS patients underwent gastric bypass <5 years from admission (61%). The OB/BS group was younger, more likely to be female, and transferred from an outside hospital. The mean BMI was highest in the OB/BS group (46.3± 14.7 kg/m 2 , P < 0.0005). Charlson Comorbidity Index was lower in the OB/BS and NOB/BS groups (2 (1-4) and 2 (2-4), respectively, P = 0.0033). Cumulative 90-day mortality was significantly lower in the OB/BS cohort (20.8%, P = 0.002). The OB/BS cohort was more likely to die from intra-abdominal sepsis not amenable to source control (60% vs. 22.5% vs. 22.8% vs. 37.5%, P = 0.04). Compared to the other groups, 90-day survival was highest in the OB/BS cohort (log-rank P < 0.009). Conclusions: This study demonstrated improvement in 90-day survival in OB/BS patients despite higher BMIs. However, this group was more likely to die from intra-abdominal sources, likely reflecting surgical complexity in the setting of prior bypasses.
与非肥胖手术患者相比,肥胖与90天死亡率较高相关。减重手术(BS)可降低肥胖相关的合并症,即使是那些仍存在肥胖的患者。目的:评估既往减重手术对肥胖手术患者脓毒症结局的影响。地点:美国大学医院。方法:对所有脓毒症(序贯器官衰竭评估[SOFA]≥2)手术患者进行单机构回顾性研究。患者分为肥胖且既往接受过减重手术(OB/BS;n = 48)、肥胖但未接受减重手术(OB;n = 717)、非肥胖(NOB;n = 574)以及非肥胖且既往接受过减重手术(NOB/BS;n = 27)四组。比较人口统计学数据、合并症及脓毒症表现。主要结局为90天累积死亡率和生存率。结果:大多数OB/BS患者在入院前<5年接受了胃旁路手术(61%)。OB/BS组患者更年轻,女性比例更高,且多从外院转入。OB/BS组的平均体重指数最高(46.3±14.7kg/m²,P<0.0005)。OB/BS组和NOB/BS组的查尔森合并症指数较低(分别为2(1 - 4)和2(2 - 4),P = 0.0033)。OB/BS队列的90天累积死亡率显著较低(20.8%,P = 0.002)。OB/BS队列死于无法通过源头控制的腹腔内脓毒症的可能性更高(60%对22.5%对22.